Skip to main content
Caplight Logo









Ilonov

Ilonov

Private
StrasbourgHealthcare & Life Scienceshttps://www.ilonov-diabetes.com/

Last Round

Accelerator

Mar 13, 2025

Total Funding Raised

$600,000

Company Overview

Ilonov is a biotechnology company that develops first-in-class biotherapies for the treatment of diabetes and metabolic diseases by leveraging the potential of the muscle secretome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologybiotherapeuticdiabetes treatmentpancreatic beta-cellmetabolic diseaseislet transplantmuscle secretomedrug discoverycell therapypreclinical researchbiotech startupmyokine therapyprecision medicineregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ilonov Comparables

Compare Ilonov with similar companies based on industry and business-model similarity.

Ilonov comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmasaga Co., Ltd.
78%
Seraxis
75%
Betalin Therapeutics
73%

Ilonov Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 13, 2025
GrantJan 22, 2023
AcceleratorJun 1, 2022
GrantSep 1, 2021
Pre SeedJan 1, 2021

Key People

Founding team and executive leadership

Anastasia Grabarz

CEO

Executive Team

Ilonov Investors

Notable investors and investment history

Ilonov investors
InvestorRounds
BaseLaunchAccelerator
Région Grand EstGrant
BpifrancePre Seed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2022

    Received funding from Business France.

  • Sep 1, 2021

    Received grant funding from Bpifrance.

Ilonov Filings

Explore SEC and related filing metadata, where available.

Ilonov filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ilonov's valuation, stock price, and market status.

Is Ilonov a public or private company?

Ilonov is a private company.

What is the current stock price of Ilonov?

Ilonov is a private company with no public stock price. No recent secondary market data is available.

How much is Ilonov worth (valuation)?

Valuation information for Ilonov is not publicly available.

Can I buy Ilonov stock?

Ilonov shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ilonov's last funding round?

Ilonov's most recent funding round was Accelerator on March 13, 2025.

Who are the main investors in Ilonov?

Key investors in Ilonov include BaseLaunch, Région Grand Est, Bpifrance.

Will Ilonov IPO soon?

No public IPO plans have been announced for Ilonov.

How can I track Ilonov secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ilonov's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStrasbourg
Employee Range4
Year Founded2020
Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?